Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia
Annals of Neurology2015Vol. 77(4), pp. 720–725
Citations Over TimeTop 1% of 2015 papers
Alissa M. D’Gama, Ying Geng, Javier Couto, Beth Martin, Evan A. Boyle, Christopher M. LaCoursiere, Amer A. Hossain, Nicole E. Hatem, Brenda J. Barry, David J. Kwiatkowski, Harry V. Vinters, A. James Barkovich, Jay Shendure, Gary W. Mathern, Christopher A. Walsh, Annapurna Poduri
Abstract
Focal malformations of cortical development, including focal cortical dysplasia (FCD) and hemimegalencephaly (HME), are important causes of intractable childhood epilepsy. Using targeted and exome sequencing on DNA from resected brain samples and nonbrain samples from 53 patients with FCD or HME, we identified pathogenic germline and mosaic mutations in multiple PI3K/AKT pathway genes in 9 patients, and a likely pathogenic variant in 1 additional patient. Our data confirm the association of DEPDC5 with sporadic FCD but also implicate this gene for the first time in HME. Our findings suggest that modulation of the mammalian target of rapamycin pathway may hold promise for malformation-associated epilepsy.
Related Papers
- → PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia(2015)362 cited
- → Focal dysplasia of the cerebral cortex and infantile spasms associated with somatic 1q21.1‐q44 duplication including the AKT3 gene(2014)97 cited
- → Neuronal Migration Disorders: A Contribution of Modern Neuroimaging to the Etiologic Diagnosis of Epilepsy(1991)121 cited
- → Radiologic-pathologic correlation in focal cortical dysplasia and hemimegalencephaly in 18 children(2001)52 cited
- → Clinical and imaging characteristics of localized megalencephaly: a retrospective comparison of diffuse hemimegalencephaly and multilobar cortical dysplasia(2009)23 cited